Target intelligence / Profile preview

Recurrent tibial genicular nerve (RTGN)

Target
RTGN
Molecular classification
Other (Anatomical Structure)
01

Overview

The recurrent tibial genicular nerve (RTGN), also frequently referred to as the recurrent peroneal genicular nerve, is a sensory nerve branch that provides innervation to the anterior and lateral aspects of the knee joint capsule, the infrapatellar fat pad, and the proximal tibiofibular joint. It typically arises from the common peroneal (fibular) nerve or the deep peroneal nerve near the fibular neck and travels proximally to reach its target tissues. In clinical practice, the RTGN is considered a significant anatomical target for interventional pain management, specifically in patients suffering from chronic knee pain due to osteoarthritis or persistent pain following total knee arthroplasty. Therapeutic interventions include diagnostic nerve blocks using local anesthetics and long-term analgesia via radiofrequency ablation, which thermally disrupts the nerve's ability to transmit pain signals. While not a molecular target in the traditional sense of a receptor or enzyme, its modulation is a cornerstone of advanced genicular neurotomy procedures used to restore function in patients who have failed conservative or surgical treatments.

Other names
Recurrent peroneal genicular nerveRecurrent articular branch of the common peroneal nerveRecurrent peroneal nerveRecurrent branch of the deep peroneal nerveAnterior recurrent tibial nerve
02

Mechanism of action

Interventional procedures such as nerve blocks or radiofrequency ablation inhibit signal conduction along the nerve fiber to prevent the transmission of nociceptive (pain) signals to the central nervous system.

03

Biological functions

Sensory innervation of the knee joint capsuleNociception (pain signaling)ProprioceptionInnervation of the infrapatellar fat padInnervation of the proximal tibiofibular joint
04

Disease associations

OsteoarthritisChronic knee painPost-surgical knee painFailed knee arthroplasty syndromePatellofemoral pain syndrome
05

Safety considerations

Motor weakness or foot drop (if the common peroneal nerve is accidentally affected)Localized infection at the injection siteHematoma or vascular injurySkin burns or deafferentation pain (associated with radiofrequency ablation)Neuritis or neuropathic pain
06

Interacting drugs

Lidocaine

5 more in the full profile.

07

Biomarkers

Diagnostic genicular nerve block response (typically >50-80% pain reduction)

Beyond the preview

Go deeper on Recurrent tibial genicular nerve (RTGN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recurrent tibial genicular nerve (RTGN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call